Minimally Invasive Surgical Instruments Market
The market for Minimally Invasive Surgical Instruments was estimated at $34.6 billion in 2024; it is anticipated to increase to $59.6 billion by 2030, with projections indicating growth to around $93.9 billion by 2035.
Global Minimally Invasive Surgical Instruments Market Outlook
Revenue, 2024
Forecast, 2034
CAGR, 2025 - 2034
The Minimally Invasive Surgical Instruments industry revenue is expected to be around $37.9 billion in 2025 and expected to showcase growth with 9.5% CAGR between 2025 and 2034. A sustained period of growth highlights how minimally invasive surgical instruments are transforming modern surgical practices. Hospitals and clinics increasingly prefer equipment that enables procedures such as laparoscopy, endoscopy, and cardiac surgeries with minimal tissue damage, shorter recovery times, and reduced hospital stays. Rising incidences of orthopedic and cardiovascular conditions, an aging population, and the focus of insurers on cost effective care are driving strong demand. Orthopedic and cardiac procedures account for nearly half of the market, while traditional handheld surgical tools still represent approximately $25.19 billion in purchasing power in 2025, even as smart devices and robotic assisted systems gain traction.
Surgeons now rely on highly precise instruments designed for controlled access and accurate manipulation. Minimally invasive surgical instruments, also known as MIS Instruments , including articulated graspers, flexible scissors, micro forceps, and camera guided tools, allow clinicians to perform delicate procedures through small incisions. Integrated lighting, ergonomic handles, and advanced articulation ensure instruments respond intuitively, enhancing dexterity while reducing tissue trauma. Imaging enabled instruments, such as endoscopic cameras and robotic assisted manipulators, provide real time visualization of anatomical structures, improving safety and outcomes. These tools are increasingly used in outpatient or short stay surgical centers, where procedures are completed in hours rather than days, reflecting a broader shift toward efficiency and precision in modern surgery.
Market Key Insights
The Minimally Invasive Surgical Instruments market is projected to grow from $34.6 billion in 2024 to $85.7 billion in 2034. This represents a CAGR of 9.5%, reflecting rising demand across Cardiothoracic Surgery, Gastrointestinal Surgery, and Orthopedic Surgery.
Companies like Medtronic hold strong positions. Alongside them, Johnson & Johnson also plays a major role. Intuitive Surgical fits into this picture just as prominently. Together, these names shift how rivals interact across the board.
The United States and China lead when it comes to demand in minimally invasive surgical tools. Growth here isn’t slowing down much. From 2024 to 2030, rates will hit between 6.9 percent and 10.0 percent annually.
Across regions like India, Brazil and Mexico, momentum builds slowly - growth here looks set to lead, driven by steady gains of between 9.1% and 11.9%.
From paper to screens - the move toward digital surgery tools could boost the minimally invasive instruments sector by six billion dollars within a decade.
The Minimally Invasive Surgical Instruments market could grow by $51.1 billion from 2024 to 2034. When it comes to who makes these tools, those focusing on Gastrointestinal and Orthopedic treatments tend to capture even more of that space over time.
With
rising chronic disease burden and aging populations accelerating demand for advanced minimally invasive surgical instruments, and
Continuous technological innovation in robotic and laparoscopic platforms enhancing precision of minimally invasive procedures, Minimally Invasive Surgical Instruments market to expand 148% between 2024 and 2034.
Opportunities in the Minimally Invasive Surgical Instruments
Growth Opportunities in North America and Asia-Pacific
Market Dynamics and Supply Chain
Driver: Rising chronic disease burden and aging populations accelerating demand for advanced minimally invasive surgical instruments
Restraint: High acquisition costs and uncertain reimbursement suppress hospital adoption of advanced minimally invasive surgical instruments
Opportunity: Rising adoption of minimally invasive surgical instruments for outpatient procedures in United States ambulatory centers and Accelerating deployment of minimally invasive surgical instruments in robotic oncology surgery within leading European hospitals
Challenge: Global supply chain fragility and skills gaps constrain procedure volumes using minimally invasive surgical instruments worldwide
Supply Chain Landscape
Materials Supply
Component Fabrication
Instrument Manufacturing
Clinical End Users
Materials Supply
Component Fabrication
Instrument Manufacturing
Clinical End Users
Use Cases of Minimally Invasive Surgical Instruments in Cardiothoracic Surgery & Gastrointestinal Surgery
Recent Developments
Smart tools in surgery are getting sharper, thanks to better grip design and precise energy delivery. Laparoscopy kits have evolved quietly, offering more control without extra bulk. Robots now assist surgeons with greater reliability during complex operations. Outpatient clinics take delivery of flexible scopes faster each year, swapping long hospital stays for quicker exits. Recovery slows down less when machines handle parts of the work. Fewer hiccups in treatment log appear alongside wider acceptance of remote setups.